SuperworthBio-Rad Laboratories market cap BIO
Share price times shares outstanding: what the whole company sells for, since 2011.
- Today, Oct 23, 2026
- $9.9B
- Highest close in our data
- $24.4B
- Sep 2021
Bio-Rad Laboratories is worth $9.9B at the close on Oct 23, 2026, at $369.95 a share.
That is up 8% over the last year and down 58% over five years.
Its highest close in our data was $24.4B in Sep 2021.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $9.9B | $6.6B | $10.4B | +21% |
| 2025 | $8.2B | $6B | $10.1B | −12% |
| 2024 | $9.3B | $7.8B | $10.3B | −2% |
| 2023 | $9.4B | $7.9B | $15B | −25% |
| 2022 | $12.5B | $10.5B | $19.8B | −45% |
| 2021 | $22.6B | $16.7B | $24.4B | +30% |
| 2020 | $17.4B | $9.6B | $19.2B | +58% |
| 2019 | $11B | $6.8B | $11.2B | +60% |
| 2018 | $6.9B | $6.8B | $9.7B | −3% |
| 2017 | $7.1B | $5.5B | $8B | +32% |
| 2016 | $5.4B | $3.7B | $5.4B | +33% |
| 2015 | $4.1B | $3.3B | $4.4B | +16% |
| 2014 | $3.5B | $3.1B | $3.8B | −2% |
| 2013 | $3.6B | $3.1B | $3.6B | +21% |
| 2012 | $3B | $2.7B | $3.2B | +9% |
| 2011 | $2.7B | $2.5B | $2.9B | n/a |
Against its peers
Companies in Medical - Diagnostics & Research nearest Bio-Rad Laboratories' size, closest first, today.
| Company | Market cap |
|---|---|
| BIOBio-Rad Laboratories | $9.9B |
| CAICaris Life Sciences | $9B |
| LNTHLantheus | $6.5B |
| RVTYRevvity | $17.7B |
| MEDPMedpace | $18.7B |
| BLLNBillionToOne | $5.1B |
| VCYTVeracyte | $3.9B |
| LHLabcorp | $26.7B |
| DGXQuest Diagnostics | $26.7B |
| CDNACareDx | $3.6B |
| MTDMettler-Toledo International | $33.5B |
| Peer median | $13.4B |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Bio-Rad Laboratories
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.